190 related articles for article (PubMed ID: 25895648)
1. Semaphorin 3A: an immunoregulator in systemic sclerosis.
Rimar D; Nov Y; Rosner I; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Vadasz Z
Rheumatol Int; 2015 Oct; 35(10):1625-30. PubMed ID: 25895648
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.
Vadasz Z; Haj T; Halasz K; Rosner I; Slobodin G; Attias D; Kessel A; Kessler O; Neufeld G; Toubi E
Arthritis Res Ther; 2012 Jun; 14(3):R146. PubMed ID: 22697500
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.
Kayaalp M; Erden A; Apaydin H; Güven SC; Armağan B; Cağlayan Kayaalp M; Andac Uzdogan E; Ala Enli Ş; Omma A; Kucuksahin O
Lab Med; 2023 Nov; 54(6):646-651. PubMed ID: 37100766
[TBL] [Abstract][Full Text] [Related]
4. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
[TBL] [Abstract][Full Text] [Related]
5. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus].
Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195
[No Abstract] [Full Text] [Related]
6. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus.
Wang P; Mao YM; Liu LN; Zhao CN; Li XM; Pan HF
Immunol Invest; 2020 Feb; 49(1-2):69-80. PubMed ID: 31412748
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3A, a potential immune regulator in familial Mediterranean fever.
Rimar D; Rosner I; Slobodin G; Rozenbaum M; Halasz K; Jiries N; Kaly L; Boulman N; Vadasz Z
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S52-S55. PubMed ID: 27157528
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.
Vadasz Z; Toubi E
Lupus; 2012 Oct; 21(12):1266-70. PubMed ID: 22875653
[TBL] [Abstract][Full Text] [Related]
9. [Association of Semaphorin 3A with thrombocytopenia in systemic lupus erythematosus].
Guo Q; Ma XX; Gao H; Shi LJ; Zhong YC; Xie LF; Shao M; Zhang XW
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):892-896. PubMed ID: 33047725
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin-3A,
Liu LN; Wang P; Zou YF; Xu Z; Cheng J; Zhang Y; Hu W; Pan HF
Autoimmunity; 2019 Jun; 52(4):161-167. PubMed ID: 31394943
[No Abstract] [Full Text] [Related]
11. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of semaphorin-3A in autoimmune diseases.
Liu LN; Li XM; Ye DQ; Pan HF
Inflammopharmacology; 2018 Jun; 26(3):655-665. PubMed ID: 29696565
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
14. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria.
Doron R; Merav L; Nasrin E; Adi SD; Elias T; Gleb S; Itzhak R; Michael R; Zahava V
Inflammation; 2022 Apr; 45(2):603-609. PubMed ID: 34562225
[TBL] [Abstract][Full Text] [Related]
15. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E
Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients.
Rezaeepoor M; Shapoori S; Ganjalikhani-Hakemi M; Etemadifar M; Alsahebfosoul F; Eskandari N; Mansourian M
Gene; 2017 Apr; 610():59-63. PubMed ID: 28188869
[TBL] [Abstract][Full Text] [Related]
17. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
Catalano A
J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
Jiang N; Li M; Zeng X
Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 3A: Is a key player in the pathogenesis of asthma.
Cozacov R; Halasz K; Haj T; Vadasz Z
Clin Immunol; 2017 Nov; 184():70-72. PubMed ID: 28502680
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance?
Cernaro V; Lucisano S; Buemi A; Visconti L; Lacava V; Lacquaniti A; Santoro D; Loddo S; Buemi M
Nephrology (Carlton); 2015 Apr; 20(4):236-42. PubMed ID: 25560370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
